A carregar...
Mechanisms of failure of chimeric antigen receptor T-cell therapy
Although chimeric antigen receptor T (CART)-cell therapy is best recognized for its antitumor effect in relapsed/refractory B-cell hematological cancers, it is still associated with a high relapse rate. RECENT FINDINGS: We firstly analyzed internal immunological and genetic reasons of CD19+ relapse...
Na minha lista:
| Publicado no: | Curr Opin Hematol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams And Wilkins
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6791516/ https://ncbi.nlm.nih.gov/pubmed/31577606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOH.0000000000000548 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|